{"id":"NCT02730299","sponsor":"Gamida Cell ltd","briefTitle":"Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS","officialTitle":"A Multicenter, Randomized, Phase III Registration Trial of Transplantation of NiCord®, Ex Vivo Expanded, UCB-derived, Stem and Progenitor Cells, vs. Unmanipulated UCB for Patients With Hematological Malignancies","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-12-16","primaryCompletion":"2021-04-29","completion":"2025-02-07","firstPosted":"2016-04-06","resultsPosted":"2022-10-25","lastUpdate":"2025-04-06"},"enrollment":125,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hematological Malignancies","Acute Lymphoblastic Leukemia (ALL)","Acute Myelogenous Leukemia (AML)","Chronic Myelogenous Leukemia (CML)","Myelodysplastic Syndrome (MDS)","Lymphoma","Acute Leukemia"],"interventions":[{"type":"DRUG","name":"NiCord® (omidubicel)","otherNames":[]},{"type":"OTHER","name":"Cord Blood Unit","otherNames":[]}],"arms":[{"label":"NiCord® (omidubicel)","type":"EXPERIMENTAL"},{"label":"Unmanipulated CBU(s)","type":"ACTIVE_COMPARATOR"}],"summary":"This study is an open-label, controlled, multicenter, international, Phase III, randomized study of transplantation of NiCord® versus transplantation of one or two unmanipulated, unrelated cord blood units in patients with acute lymphoblastic leukemia or acute myeloid leukemia, myelodysplastic syndrome, chronic myeloid leukemia or lymphoma, all with required disease features rendering them eligible for allogeneic transplantation.","primaryOutcome":{"measure":"Time to Neutrophil Engraftment","timeFrame":"post-transplant up to 42 days","effectByArm":[{"arm":"NiCord® (Omidubicel)","deltaMin":12,"sd":null},{"arm":"Unmanipulated Cord Blood Unit(s)","deltaMin":22,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":52,"countries":["United States","Brazil","France","Israel","Italy","Netherlands","Portugal","Singapore","Spain","United Kingdom"]},"refs":{"pmids":["37703995","37120136","34157093","33811823"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":47,"n":52},"commonTop":["Pyrexia","Gastrointestinal Toxicity","Mucosal Inflammation","Pain","Vomiting"]}}